<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR57">
 <label>57.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Reck</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Rodriguez-Abreu</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Robinson</surname>
    <given-names>AG</given-names>
   </name>
   <name>
    <surname>Hui</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Csoszi</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Fulop</surname>
    <given-names>A</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer</article-title>
  <source>N Engl J Med</source>
  <year>2016</year>
  <volume>375</volume>
  <fpage>1823</fpage>
  <lpage>1833</lpage>
  <pub-id pub-id-type="doi">10.1056/NEJMoa1606774</pub-id>
  <?supplied-pmid 27718847?>
  <pub-id pub-id-type="pmid">27718847</pub-id>
 </element-citation>
</ref>
